Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Feb 10, 2022	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001037389-22-000026.pdf 0001037389-22-000026.rtf
Feb 4, 2022	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001062993-22-002544.pdf 0001062993-22-002544.rtf 0001062993-22-002544.xls
Jan 19, 2022	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902664-22-000336.pdf 0000902664-22-000336.rtf 0000902664-22-000336.xls
Jan 18, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001891257-22-000004.pdf 0001891257-22-000004.rtf 0001891257-22-000004.xls
Jan 18, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001334549-22-000004.pdf 0001334549-22-000004.rtf 0001334549-22-000004.xls
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001373585-22-000002.pdf 0001373585-22-000002.rtf 0001373585-22-000002.xls
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001573785-22-000002.pdf 0001573785-22-000002.rtf 0001573785-22-000002.xls
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001741455-22-000002.pdf 0001741455-22-000002.rtf 0001741455-22-000002.xls
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001192621-22-000002.pdf 0001192621-22-000002.rtf 0001192621-22-000002.xls
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001078274-22-000002.pdf 0001078274-22-000002.rtf 0001078274-22-000002.xls